{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T23:55:44Z","timestamp":1788306944390,"version":"build-2803163510"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T00:00:00Z","timestamp":1717113600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Hormones"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1007\/s42000-024-00569-4","type":"journal-article","created":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T07:01:27Z","timestamp":1717138887000},"page":"717-725","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Somatic USP8 alteration affects the immune landscape of corticotroph pituitary adenomas\u2013 a pilot study"],"prefix":"10.1007","volume":"23","author":[{"given":"Dahlia","family":"Greidinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reut","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roni","family":"Zemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitzan","family":"Maixner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3794-9634","authenticated-orcid":false,"given":"Amit","family":"Tirosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,31]]},"reference":[{"issue":"5","key":"569_CR1","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1001\/jama.2016.19699","volume":"317","author":"ME Molitch","year":"2017","unstructured":"Molitch ME (2017) Diagnosis and treatment of pituitary adenomas: a review. JAMA 317(5):516\u2013524. https:\/\/doi.org\/10.1001\/jama.2016.19699","journal-title":"JAMA"},{"key":"569_CR2","volume-title":"Harrisons Principle of Internal Medicine 20t Edition","author":"J Jameson","year":"2018","unstructured":"Jameson J, Fauci AS, Kasper DL, Hauser SL, Longo DL, Loscalzo J (2018) Harrisons Principle of Internal Medicine 20t Edition. McGraw-Hill Education, New York"},{"issue":"4","key":"569_CR3","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.beem.2012.01.002","volume":"26","author":"O Cooper","year":"2012","unstructured":"Cooper O, Melmed S (2012) Subclinical hyperfunctioning pituitary adenomas: the silent tumors. Best Pract Res Clin Endocrinol Metab 26(4):447\u2013460. https:\/\/doi.org\/10.1016\/j.beem.2012.01.002","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"issue":"2","key":"569_CR4","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s11102-018-0864-8","volume":"21","author":"A Ben-Shlomo","year":"2018","unstructured":"Ben-Shlomo A, Cooper O (2018) Silent corticotroph adenomas. Pituitary 21(2):183\u2013193. https:\/\/doi.org\/10.1007\/s11102-018-0864-8","journal-title":"Pituitary"},{"key":"569_CR5","doi-asserted-by":"publisher","unstructured":"Zinngrebe J, Montinaro A, Peltzer N, Walczak H (2014) Ubiquitin in the immune system. [published correction appears in EMBO Rep. 2014;15(3):322]. EMBO Rep 15(1):28\u201345. https:\/\/doi.org\/10.1002\/embr.201338025","DOI":"10.1002\/embr.201338025"},{"key":"569_CR6","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/cr.2015.20","volume":"25","author":"ZY Ma","year":"2015","unstructured":"Ma ZY, Song ZJ, Chen JH et al (2015) Recurrent gain-of-function USP8 mutations in Cushing\u2019s disease. Cell Res 25:306\u2013317. https:\/\/doi.org\/10.1038\/cr.2015.20","journal-title":"Cell Res"},{"issue":"4","key":"569_CR7","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/s11102-019-00973-9","volume":"22","author":"IQ Wanichi","year":"2019","unstructured":"Wanichi IQ, de Paula Mariani BM, Frassetto FP et al (2019) Cushing\u2019s disease due to somatic USP8 mutations: a systematic review and meta-analysis. Pituitary 22(4):435\u2013442. https:\/\/doi.org\/10.1007\/s11102-019-00973-9","journal-title":"Pituitary"},{"issue":"6","key":"569_CR8","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1530\/eje-19-0194","volume":"181","author":"M Bujko","year":"2019","unstructured":"Bujko M, Kober P, Boresowicz J et al (2019) USP8 mutations in corticotroph adenomas determine a distinct gene expression profile irrespective of functional tumour status. Eur J Endocrinol 181(6):615\u2013627. https:\/\/doi.org\/10.1530\/eje-19-0194","journal-title":"Eur J Endocrinol"},{"key":"569_CR9","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/ng.3166","volume":"47","author":"M Komada","year":"2015","unstructured":"Komada M (2015) Mutations in the deubiquitinase gene USP8 cause Cushing\u2019s disease. Nat Genet 47:31\u201338. https:\/\/doi.org\/10.1038\/ng.3166","journal-title":"Nat Genet"},{"issue":"7","key":"569_CR10","doi-asserted-by":"publisher","first-page":"E997","DOI":"10.1210\/jc.2015-1453","volume":"100","author":"LG Perez-Rivas","year":"2015","unstructured":"Perez-Rivas LG, Theodoropoulou M, Ferra\u00f9 F et al (2015) The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing cushing\u2019s disease. J Clin Endocrinol Metab 100(7):E997\u2013E1004. https:\/\/doi.org\/10.1210\/jc.2015-1453","journal-title":"J Clin Endocrinol Metab"},{"issue":"2","key":"569_CR11","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1530\/EJE-15-0689","volume":"174","author":"K Hayashi","year":"2016","unstructured":"Hayashi K, Inoshita N, Kawaguchi K et al (2016) The USP8 mutational status may predict drug susceptibility in corticotroph adenomas of Cushing\u2019s disease. Eur J Endocrinol 174(2):213\u2013226. https:\/\/doi.org\/10.1530\/EJE-15-0689","journal-title":"Eur J Endocrinol"},{"key":"569_CR12","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/s12020-018-1776-0","volume":"63","author":"M Losa","year":"2019","unstructured":"Losa M, Mortini P, Pagnano A et al (2019) Clinical characteristics and surgical outcome in USP8-mutated human adrenocorticotropic hormone-secreting pituitary adenomas. Endocrine 63:240\u2013246. https:\/\/doi.org\/10.1007\/s12020-018-1776-0","journal-title":"Endocrine"},{"key":"569_CR13","doi-asserted-by":"crossref","unstructured":"Centorrino F, Ballone A, Wolter M, Ottmann C (2018) Biophysical and structural insight into the USP8\/14-3-3 interaction. FEBS Lett","DOI":"10.1002\/1873-3468.13017"},{"key":"569_CR14","doi-asserted-by":"publisher","first-page":"3624","DOI":"10.1016\/j.yexcr.2007.07.028","volume":"313","author":"E Mizuno","year":"2007","unstructured":"Mizuno E, Kitamura N, Komada M (2007) 14-3-3-dependent inhibition of the deubiquitinating activity of UBPY and its cancellation in the M phase. Exp Cell Res 313:3624\u20133634. https:\/\/doi.org\/10.1016\/j.yexcr.2007.07.028","journal-title":"Exp Cell Res"},{"key":"569_CR15","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/j.mce.2018.01.020","volume":"473","author":"P Kober","year":"2018","unstructured":"Kober P, Boresowicz J, Rusetska N et al (2018) DNA methylation profiling in nonfunctioning pituitary adenomas. Mol Cell Endocrinol 473:194\u2013204. https:\/\/doi.org\/10.1016\/j.mce.2018.01.020","journal-title":"Mol Cell Endocrinol"},{"key":"569_CR16","doi-asserted-by":"publisher","unstructured":"Sj\u00f6stedt E, Zhong W, Fagerberg L et al (2020) An atlas of the protein-coding genes in the human, pig, and mouse brain. Science (1979) 367(6482):eaay5947. https:\/\/doi.org\/10.1126\/science.aay5947","DOI":"10.1126\/science.aay5947"},{"key":"569_CR17","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.semcancer.2006.03.009","volume":"16","author":"M-H Lee","year":"2006","unstructured":"Lee M-H, Lozano G (2006) Regulation of the p53-MDM2 pathway by 14-3-3 \u03c3 and other proteins. Semin Cancer Biol 16:225\u2013234. https:\/\/doi.org\/10.1016\/j.semcancer.2006.03.009","journal-title":"Semin Cancer Biol"},{"key":"569_CR18","doi-asserted-by":"publisher","unstructured":"Qiu H, Kong J, Cheng Y, Li G (2018) The expression of ubiquitin-specific peptidase 8 and its prognostic role in patients with breast cancer. 119(12):10051\u201310058 J Cell Biochem. https:\/\/doi.org\/10.1002\/jcb.27337","DOI":"10.1002\/jcb.27337"},{"issue":"6","key":"569_CR19","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1111\/pin.12546","volume":"67","author":"Y Kim","year":"2017","unstructured":"Kim Y, Shiba-Ishii A, Nakagawa T et al (2017) Ubiquitin-specific protease 8 is a novel prognostic marker in early-stage lung adenocarcinoma. Pathol Int 67(6):292\u2013301. https:\/\/doi.org\/10.1111\/pin.12546","journal-title":"Pathol Int"},{"key":"569_CR20","doi-asserted-by":"publisher","first-page":"4934","DOI":"10.12659\/MSM.909235","volume":"16","author":"M Yan","year":"2018","unstructured":"Yan M, Zhao C, Wei N et al (2018) High expression of ubiquitin-specific protease 8 (USP8) is associated with poor prognosis in patients with cervical squamous cell carcinoma. Med Sci Monit 16:24:4934\u20134943. https:\/\/doi.org\/10.12659\/MSM.909235","journal-title":"Med Sci Monit"},{"issue":"9","key":"569_CR21","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/ni.3230","volume":"16","author":"A Dufner","year":"2015","unstructured":"Dufner A, Kisser A, Niendorf S et al (2015) The ubiquitin-specific protease USP8 is critical for the development and homeostasis of T cells. Nat Immunol 16(9):950\u2013960. https:\/\/doi.org\/10.1038\/ni.3230","journal-title":"Nat Immunol"},{"key":"569_CR22","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.mcn.2014.05.004","volume":"64","author":"L Zhu","year":"2015","unstructured":"Zhu L, Bi W, Lu D et al (2015) Regulation of ubiquitin-specific processing protease 8 suppresses neuroinflammation. Mol Cell Neurosci 64:74\u201383. https:\/\/doi.org\/10.1016\/j.mcn.2014.05.004","journal-title":"Mol Cell Neurosci"},{"key":"569_CR23","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S (2014) Moderated estimation of Fold change and dispersion for RNA-seq data with DESeq2. Genome Biol 15:550. https:\/\/doi.org\/10.1186\/s13059-014-0550-8","journal-title":"Genome Biol"},{"key":"569_CR24","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, Liu CL, Green MR et al (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat Methods 12:453\u2013457. https:\/\/doi.org\/10.1038\/nmeth.3337","journal-title":"Nat Methods"},{"key":"569_CR25","doi-asserted-by":"publisher","first-page":"5387","DOI":"10.1038\/s41388-018-0342-9","volume":"37","author":"Y Kim","year":"2018","unstructured":"Kim Y, Shiba-Ishii A, Nakagawa T et al (2018) Stratifin regulates stabilization of receptor tyrosine kinases via interaction with ubiquitin-specific protease 8 in lung adenocarcinoma. Oncogene 37:5387\u20135402. https:\/\/doi.org\/10.1038\/s41388-018-0342-9","journal-title":"Oncogene"},{"key":"569_CR26","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.immuni.2019.08.004","volume":"51","author":"V Thorsson","year":"2019","unstructured":"Thorsson V, Gibbs DL, Brown SD et al (2019) The Immune Landscape of Cancer. Immunity 51:411\u2013412. https:\/\/doi.org\/10.1016\/j.immuni.2019.08.004","journal-title":"Immunity"},{"key":"569_CR27","doi-asserted-by":"publisher","unstructured":"Khosravi G, Mostafavi S, Bastan S et al (2024) Immunologic tumor microenvironment modulators for turning cold tumors hot. Cancer Commun. 2024; 1\u201333. https:\/\/doi.org\/10.1002\/cac2.12539","DOI":"10.1002\/cac2.12539"},{"key":"569_CR28","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-24277-4","volume-title":"ggplot2: elegant graphics for data analysis","author":"H Whickham","year":"2016","unstructured":"Whickham H (2016) ggplot2: elegant graphics for data analysis. Springer-, New York"},{"key":"569_CR29","unstructured":"Kassambara A (2019) ggpubr: ggplot2 Based Publication Ready Plots. R package version 0.2.3. https:\/\/CRANR-project.org\/package=ggpubr"},{"key":"569_CR30","doi-asserted-by":"publisher","first-page":"D661","DOI":"10.1093\/nar\/gkx1064","volume":"46","author":"DN Slenter","year":"2018","unstructured":"Slenter DN, Kutmon M, Hanspers K et al (2018) WikiPathways: a multifaceted pathway database bridging metabolomics to other omics research. Nucleic Acids Res 46:D661\u2013D667. https:\/\/doi.org\/10.1093\/nar\/gkx1064","journal-title":"Nucleic Acids Res"},{"key":"569_CR31","doi-asserted-by":"publisher","first-page":"D498","DOI":"10.1093\/nar\/gkz1031","volume":"48","author":"B Jassal","year":"2019","unstructured":"Jassal B, Matthews L, Viteri G et al (2019) The reactome pathway knowledgebase. Nucleic Acids Res 48:D498\u2013D503. https:\/\/doi.org\/10.1093\/nar\/gkz1031","journal-title":"Nucleic Acids Res"},{"key":"569_CR32","doi-asserted-by":"publisher","first-page":"W90","DOI":"10.1093\/nar\/gkw377","volume":"44","author":"MV Kuleshov","year":"2016","unstructured":"Kuleshov MV, Jones MR, Rouillard AD et al (2016) Enrichr: a comprehensive gene set enrichment analysis web server 2016 update. Nucleic Acids Res 44:W90\u2013W97. https:\/\/doi.org\/10.1093\/nar\/gkw377","journal-title":"Nucleic Acids Res"},{"key":"569_CR33","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/s43018-023-00521-2","volume":"4","author":"DE Speiser","year":"2023","unstructured":"Speiser DE, Chijioke O, Schaeuble K, M\u00fcnz C (2023) CD4\u2009+\u2009T cells in cancer. Nat Cancer 4:317\u2013329. https:\/\/doi.org\/10.1038\/s43018-023-00521-2","journal-title":"Nat Cancer"},{"key":"569_CR34","doi-asserted-by":"publisher","first-page":"799","DOI":"10.1038\/s41573-022-00520-5","volume":"21","author":"A Mantovani","year":"2022","unstructured":"Mantovani A, Allavena P, Marchesi F, Garlanda C (2022) Macrophages as tools and targets in cancer therapy. Nat Rev Drug Discov 21:799\u2013820. https:\/\/doi.org\/10.1038\/s41573-022-00520-5","journal-title":"Nat Rev Drug Discov"},{"key":"569_CR35","doi-asserted-by":"publisher","first-page":"7748","DOI":"10.1128\/MCB.24.17.7748-7757.2004","volume":"24","author":"X Wu","year":"2004","unstructured":"Wu X, Yen L, Irwin L et al (2004) Stabilization of the E3 ubiquitin ligase Nrdp1 by the deubiquitinating enzyme USP8. Mol Cell Biol 24:7748\u20137757. https:\/\/doi.org\/10.1128\/MCB.24.17.7748-7757.2004","journal-title":"Mol Cell Biol"},{"key":"569_CR36","doi-asserted-by":"publisher","first-page":"744","DOI":"10.1038\/ni.1742","volume":"10","author":"C Wang","year":"2009","unstructured":"Wang C, Chen T, Zhang J et al (2009) The E3 ubiquitin ligase Nrdp1 preferentially promotes TLR-mediated production of type I interferon. Nat Immunol 10:744\u2013752. https:\/\/doi.org\/10.1038\/ni.1742","journal-title":"Nat Immunol"},{"key":"569_CR37","doi-asserted-by":"publisher","first-page":"26740","DOI":"10.1074\/jbc.M112.383265","volume":"287","author":"S Ye","year":"2012","unstructured":"Ye S, Xu H, Jin J et al (2012) The E3 Ubiquitin Ligase Neuregulin Receptor Degradation Protein 1 (Nrdp1) promotes M2 macrophage polarization by Ubiquitinating and activating transcription factor CCAAT\/Enhancer-binding protein \u03b2 (C\/EBP\u03b2). J Biol Chem 287:26740\u201326748. https:\/\/doi.org\/10.1074\/jbc.M112.383265","journal-title":"J Biol Chem"},{"key":"569_CR38","doi-asserted-by":"publisher","first-page":"4313","DOI":"10.3892\/mmr.2018.9486","volume":"18","author":"B Ma","year":"2018","unstructured":"Ma B, Yang Y, Li Z et al (2018) Modular bioinformatics analysis demonstrates that a Tolllike receptor signaling pathway is involved in the regulation of macrophage polarization. Mol Med Rep 18:4313\u20134320. https:\/\/doi.org\/10.3892\/mmr.2018.9486","journal-title":"Mol Med Rep"},{"issue":"7","key":"569_CR39","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1038\/s41423-020-0411-1","volume":"18","author":"Y-H Hu","year":"2020","unstructured":"Hu Y-H, Wang Y, Wang F et al (2020) SPOP negatively regulates toll-like receptor-induced inflammation by disrupting MyD88 self-association. Cell Mol Immunol 18(7):1708\u20131717. https:\/\/doi.org\/10.1038\/s41423-020-0411-1","journal-title":"Cell Mol Immunol"},{"issue":"10","key":"569_CR40","doi-asserted-by":"publisher","first-page":"1935","DOI":"10.1093\/annonc\/mdu242","volume":"25","author":"K Azuma","year":"2014","unstructured":"Azuma K, Ota K, Kawahara A et al (2014) Association of PD-L1 overexpression with activating EGFR mutations in surgically resected nonsmall-cell lung cancer. Annals Oncology: Official J Eur Soc Med Oncol \/ ESMO 25(10):1935\u20131940. https:\/\/doi.org\/10.1093\/annonc\/mdu242","journal-title":"Annals Oncology: Official J Eur Soc Med Oncol \/ ESMO"},{"key":"569_CR41","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1038\/bjc.2014.555","volume":"112","author":"A D\u2019Incecco","year":"2015","unstructured":"D\u2019Incecco A, Andreozzi M, Ludovini V et al (2015) PD-1 and PD-L1 expression in molecularly selected non-small-cell lung cancer patients. Br J Cancer 112:95\u2013102. https:\/\/doi.org\/10.1038\/bjc.2014.555","journal-title":"Br J Cancer"},{"key":"569_CR42","doi-asserted-by":"publisher","first-page":"14209","DOI":"10.18632\/oncotarget.3694","volume":"6","author":"Y Tang","year":"2015","unstructured":"Tang Y, Fang W, Zhang Y et al (2015) The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs. Oncotarget 6:14209\u201314219. https:\/\/doi.org\/10.18632\/oncotarget.3694","journal-title":"Oncotarget"},{"issue":"13","key":"569_CR43","doi-asserted-by":"publisher","first-page":"4400","DOI":"10.1158\/1078-0432.CCR-10-3283","volume":"17","author":"BP Pollack","year":"2011","unstructured":"Pollack BP, Sapkota B, Cartee TV (2011) Epidermal growth factor receptor inhibition augments the expression of MHC class I and II genes. Clin Cancer Res 17(13):4400\u20134413. https:\/\/doi.org\/10.1158\/1078-0432.CCR-10-3283","journal-title":"Clin Cancer Res"},{"issue":"11","key":"569_CR44","doi-asserted-by":"publisher","first-page":"e1356145","DOI":"10.1080\/2162402X.2017.1356145","volume":"6","author":"ZY Dong","year":"2017","unstructured":"Dong ZY, Zhang JT, Liu SY et al (2017) EGFR mutation correlates with uninflamed phenotype and weak immunogenicity, causing impaired response to PD-1 blockade in non-small cell lung cancer. Oncoimmunology 6(11):e1356145. https:\/\/doi.org\/10.1080\/2162402X.2017.1356145","journal-title":"Oncoimmunology"},{"key":"569_CR45","unstructured":"Uniprot - USP8 https:\/\/www.uniprot.org\/uniprot\/P40818#family_and_domains"}],"container-title":["Hormones"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s42000-024-00569-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s42000-024-00569-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,28]],"date-time":"2024-10-28T10:11:45Z","timestamp":1730110305000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s42000-024-00569-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,31]]},"references-count":45,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["569"],"URL":"https:\/\/doi.org\/10.1007\/s42000-024-00569-4","relation":{},"ISSN":["1109-3099","2520-8721"],"issn-type":[{"value":"1109-3099","type":"print"},{"value":"2520-8721","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,31]]},"assertion":[{"value":"13 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study used only publicly available, anonymized data. Hence, institutional Helsinki Committee approval and informed consent were not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and informed consent"}},{"value":"The authors have nothing to disclose.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosure"}},{"value":"The authors declare they have no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}